The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays a Positive Role in Treatment of Acute Lung Injury In Vivo

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Yang, Yi ^a   Hu, Shuling ^a   Xu, Xiuping ^a   Li, Jinze ^a   Liu, Airan ^a   Han, Jibin ^a   Liu, Songqiao ^a   Liu, Ling ^a   Qiu, Haibo ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; LENTIVIRUS VECTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; LUNG ENDOTHELIUM; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ACUTE LUNG INJURY; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED; EDEMA; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LUNG; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TUNEL ASSAY;

ACUTE LUNG INJURY; ANIMALS; CELLS, CULTURED; EDEMA; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LUNG; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84975126883     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/2347938     Document Type: Article

References (37)

1. "Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome," The New England Journal of Medicine, vol. 342, no. 18, pp. 1301-1308, 2000.
2. H. P. Wiedemann, A. P. Wheeler, G. R. Bernard et al., "Comparison of two fluid-management strategies in acute lung injury," The New England Journal of Medicine, vol. 354, no. 24, pp. 2564-2575, 2006.
3. C. Guérin, J. Reignier, J.-C. Richard et al., "Prone positioning in severe acute respiratory distress syndrome," The New England Journal of Medicine, vol. 368, no. 23, pp. 2159-2168, 2013.
4. S. L. Hu, H. L. He, C. Pan et al., "The effect of prone positioning on mortality in patients with acute respiratory distress syndrome: ameta-analysis of randomized controlled trials," Critical Care, vol. 18, no. 3, article R109, 2014.
5. L. Papazian, J.-M. Forel, A. Gacouin et al., "Neuromuscular blockers in early acute respiratory distress syndrome," The New England Journal of Medicine, vol. 363, no. 12, pp. 1107-1116, 2010.
6. E. Buregeya, R. A. Fowler, D. S. Talmor, T. Twagirumugabe, W. Kiviri, and E. D. Riviello, "Acute respiratory distress syndrome in the global context," Global Heart, vol. 9, no. 3, pp. 289-295, 2014.
7. L. B. Ware and M. A. Matthay, "The acute respiratory distress syndrome," The New England Journal of Medicine, vol. 342, no. 18, pp. 1334-1349, 2000.
8. X. Liang, Y. Ding, Y. Zhang, H.-F. Tse, and Q. Lian, "Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives," Cell Transplantation, vol. 23, no. 9, pp. 1045-1059, 2014.
9. M. S.H. Ho, S. H. J. Mei, and D. J. Stewart, "The immunomodulatory and therapeutic effects of mesenchymal stromal cells for acute lung injury and sepsis," Journal of Cellular Physiology, vol. 230, no. 11, pp. 2606-2617, 2015.
10. C. Liu, Y. Fan, L. Zhou et al., "Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction," International Journal of Cardiology, vol. 188, no. 1, pp. 22-32, 2015.
11. S.-P. Wang, Z.-H. Wang, D.-Y. Peng, S.-M. Li, H. Wang, and X.-H. Wang, "Therapeutic effect of mesenchymal stem cells in rats with intracerebral hemorrhage: reduced apoptosis and enhanced neuroprotection," Molecular Medicine Reports, vol. 6, no. 4, pp. 848-854, 2012.
12. T. Okazaki, T. Magaki, M. Takeda et al., "Intravenous administration of bone marrow stromal cells increases survivin and Bcl-2 protein expression and improves sensorimotor function following ischemia in rats," Neuroscience Letters, vol. 430, no. 2, pp. 109-114, 2008.
13. J.-M. Tang, J.-N. Wang, L. Zhang et al., "VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart," Cardiovascular Research, vol. 91, no. 3, pp. 402-411, 2011.
14. J. W. Lee, X. Fang, A. Krasnodembskaya, J. P. Howard, and M. A. Matthay, "Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors," STEM CELLS, vol. 29, no. 6, pp. 913-919, 2011.
15. P. R. Crisostomo, Y. Wang, T. A. Markel, M. Wang, T. Lahm, and D. R. Meldrum, "Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NFκB-but not JNK-dependent mechanism," American Journal of Physiology-Cell Physiology, vol. 294, no. 3, pp. C675-C682, 2008.
16. T. Kinnaird, E. Stabile, M. S. Burnett et al., "Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrinemechanisms," Circulation, vol. 109, no. 12, pp. 1543-1549, 2004.
17. A.-R. Liu, L. Liu, S. Chen et al., "Activation of canonical wnt pathway promotes differentiation of mouse bone marrowderived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro," Journal of Cellular Physiology, vol. 228, no. 6, pp. 1270-1283, 2013.
18. H. He, L. Liu, Q. Chen et al., "Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury," Cell Transplantation, vol. 24, no. 9, pp. 1699-1715, 2015.
19. M. A. Matthay, "Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome," Annals of the American Thoracic Society, vol. 12, supplement 1, pp. S54-S57, 2015.
20. S. Barratt, A. R. Medford, and A. B. Millar, "Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome," Respiration, vol. 87, no. 4, pp. 329-342, 2014.
21. J. Song, H. Lu, X. Zheng, and X. Huang, "Effects of vascular endothelial growth factor in recovery phase of acute lung injury in mice," Lung, vol. 193, no. 6, pp. 1029-1036, 2015.
22. L. Zhang, H. Liu, Y.-M. Peng, Y.-Y. Dai, and F.-Y. Liu, "Vascular endothelial growth factor increases GEnC permeability by affecting the distributions of occludin, ZO-1 and tight juction assembly," European Review for Medical and Pharmacological Sciences, vol. 19, no. 14, pp. 2621-2627, 2015.
23. R. Madonna, L. Petrov, M. A. Teberino et al., "Transplantation of adipose tissue mesenchymal cells conjugated with VEGFreleasing microcarriers promotes repair in murine myocardial infarction," Cardiovascular Research, vol. 108, no. 1, pp. 39-49, 2015.
24. Y. Kim, S. H. Jo, W. H. Kim, and O. Kweon, "Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury," Stem Cell Research & Therapy, vol. 6, no. 1, article 299, 2015.
25. Y.-M. Pers, M. Ruiz, D. Noël, and C. Jorgensen, "Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives," Osteoarthritis and Cartilage, vol. 23, no. 11, pp. 2027-2035, 2015.
26. F. F. Cruz, Z. D. Borg, M. Goodwin et al., "Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates Aspergillus hyphal extractinduced allergic airway inflammation in immunocompetent mice," Stem Cells Translational Medicine, vol. 4, no. 11, pp. 1302-1316, 2015.
27. A. Karihaloo, S. A. Karumanchi, W. L. Cantley, S. Venkatesha, L. G. Cantley, and S. Kale, "Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion," Molecular and Cellular Biology, vol. 25, no. 17, pp. 7441-7448, 2005.
28. Y.-G. Kim, S.-I. Suga, D.-H. Kang et al., "Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy," Kidney International, vol. 58, no. 6, pp. 2390-2399, 2000.
29. K. R. S. Brown, K. M. England, K. L. Goss, J.M. Snyder, and M. J. Acarregui, "VEGF induces airway epithelial cell proliferation in human fetal lung in vitro," American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 281, no. 4, pp. L1001-L1010, 2001.
30. V. Compernolle, K. Brusselmans, T. Acker et al., "Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice," Nature Medicine, vol. 8, no. 7, pp. 702-710, 2002.
31. G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, "Vascular-specific growth factors and blood vessel formation," Nature, vol. 407, no. 6801, pp. 242-248, 2000.
32. R. J. Kaner, J. V. Ladetto, R. Singh, N. Fukuda, M. A. Matthay, and R. G. Crystal, "Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema," American Journal of Respiratory Cell and Molecular Biology, vol. 22, no. 6, pp. 657-664, 2000.
33. K. Tang, H. B. Rossiter, P. D. Wagner, and E. C. Breen, "Lungtargeted VEGF inactivation leads to an emphysema phenotype in mice," Journal of Applied Physiology, vol. 97, no. 4, pp. 1559-1566, 2004.
34. G. D. Perkins, J. Roberts, D. F. McAuley et al., "Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury," Thorax, vol. 60, no. 2, pp. 153-158, 2005.
35. D. R. Thickett, L. Armstrong, and A. B. Millar, "A role for vascular endothelial growth factor in acute and resolving lung injury," American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 10, pp. 1332-1337, 2002.
36. M. Mura, C. C. Dos Santos, D. Stewart, and M. Liu, "Vascular endothelial growth factor and related molecules in acute lung injury," Journal of Applied Physiology, vol. 97, no. 5, pp. 1605-1617, 2004.
37. B. Maitre, S. Boussat, D. Jean et al., "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury," European Respiratory Journal, vol. 18, no. 1, pp. 100-106, 2001.